Posters and Presentations
“Cotargeting of PIM, PI3K and Mtor in Mantle Cell Lymphoma (MCL)”
57th ASH Annual Meeting, Orlando, December 5-8, 2015.
"Initial Evaluation of Novel Dual PIM/PI3K and Triple PIM/PI3K/MTOR inhibitors in multiple myeloma"
20th Congress of the European Hematology Association (EHA) June 11 – 14, 2015, Vienna.